{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:52:21Z","timestamp":1761562341541,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10147-018-1249-8","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T08:55:08Z","timestamp":1518598508000},"page":"715-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term outcomes of postoperative taxane\/platinum chemotherapy for early stage cervical cancer: a retrospective study"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-856X","authenticated-orcid":false,"given":"Mika","family":"Okazawa-Sakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Okame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shiroyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"1249_CR1","unstructured":"Organization WH World Health Organization. http:\/\/www.who.int\/cancer\/prevention\/diagnosis-screening\/cervical-cancer\/en\/ . Accessed 24 May 2017"},{"key":"1249_CR2","unstructured":"Cancer Research UK. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer . Accessed 28 May 2017"},{"key":"1249_CR3","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results Program. https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html . Accessed 25 May 2017"},{"key":"1249_CR4","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Cervical Cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site . Accessed 30 May 2017"},{"issue":"8","key":"1249_CR5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters 3rd","year":"2000","unstructured":"Peters WA 3rd, Liu PY, Barrett RJ 2nd et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18(8):1606\u20131613","journal-title":"J Clin Oncol"},{"issue":"3","key":"1249_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","volume":"38","author":"G Delgado","year":"1990","unstructured":"Delgado G, Bundy B, Zaino R et al (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38(3):352\u2013357","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1249_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/gyno.1998.4960","volume":"68","author":"RE Estape","year":"1998","unstructured":"Estape RE, Angioli R, Madrigal M et al (1998) Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol 68(3):229\u2013232","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1249_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/gyno.1999.5387","volume":"73","author":"A Sedlis","year":"1999","unstructured":"Sedlis A, Bundy BN, Rotman MZ et al (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 73(2):177\u2013183","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1249_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ygyno.2004.11.007","volume":"96","author":"BJ Monk","year":"2005","unstructured":"Monk BJ, Wang J, Im S et al (2005) Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group\/Southwest Oncology Group\/Radiation Therapy Oncology Group trial. Gynecol Oncol 96(3):721\u2013728","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1249_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0090-8258(89)90598-2","volume":"33","author":"AF Fuller Jr","year":"1989","unstructured":"Fuller AF Jr, Elliott N, Kosloff C et al (1989) Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 33(1):34\u201339","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1249_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0090-8258(90)90374-T","volume":"37","author":"AP Soisson","year":"1990","unstructured":"Soisson AP, Soper JT, Clarke-Pearson DL et al (1990) Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 37(3):390\u2013395","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1249_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0360-3016(94)00391-W","volume":"31","author":"RG Stock","year":"1995","unstructured":"Stock RG, Chen AS, Flickinger JC et al (1995) Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 31(1):31\u201336","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"1249_CR13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1438::AID-CNCR10>3.0.CO;2-0","volume":"78","author":"BU Sevin","year":"1996","unstructured":"Sevin BU, Lu Y, Bloch DA et al (1996) Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 78(7):1438\u20131446","journal-title":"Cancer"},{"issue":"2","key":"1249_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-8140(99)00056-0","volume":"51","author":"A Snijders-Keilholz","year":"1999","unstructured":"Snijders-Keilholz A, Hellebrekers BW, Zwinderman AH et al (1999) Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984\u20131996). Radiother Oncol 51(2):161\u2013167","journal-title":"Radiother Oncol"},{"issue":"3","key":"1249_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ygyno.2005.01.004","volume":"97","author":"P Marchiole","year":"2005","unstructured":"Marchiole P, Buenerd A, Benchaib M et al (2005) Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 97(3):727\u2013732","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1249_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2005.05.026","volume":"99","author":"G Putte Van de","year":"2005","unstructured":"Van de Putte G, Lie AK, Vach W et al (2005) Risk grouping in stage IB squamous cell cervical carcinoma. Gynecol Oncol 99(1):106\u2013112","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1249_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ygyno.2005.08.019","volume":"100","author":"MR Chernofsky","year":"2006","unstructured":"Chernofsky MR, Felix JC, Muderspach LI et al (2006) Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol 100(2):288\u2013293","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1249_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10147-015-0806-7","volume":"20","author":"Y Ebina","year":"2015","unstructured":"Ebina Y, Yaegashi N, Katabuchi H et al (2015) Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer. Int J Clin Oncol 20(2):240\u2013248","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"1249_CR19","doi-asserted-by":"crossref","first-page":"vii27","DOI":"10.1093\/annonc\/mds268","volume":"23","author":"N Colombo","year":"2012","unstructured":"Colombo N, Carinelli S, Colombo A et al (2012) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(7):vii27\u2013vii32","journal-title":"Ann Oncol"},{"issue":"9","key":"1249_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00432-009-0560-1","volume":"135","author":"MW Beckmann","year":"2009","unstructured":"Beckmann MW, Mallmann P, Uterus Commission of the Gynecological Oncology Working G (2009) Interdisciplinary S2k guideline on the diagnosis and treatment of cervical carcinoma. J Cancer Res Clin Oncol 135(9):1197\u20131206","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9077","key":"1249_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","volume":"350","author":"F Landoni","year":"1997","unstructured":"Landoni F, Maneo A, Colombo A et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350(9077):535\u2013540","journal-title":"Lancet"},{"issue":"3","key":"1249_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ijrobp.2009.11.019","volume":"79","author":"SY Ryu","year":"2011","unstructured":"Ryu SY, Park SI, Nam BH et al (2011) Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol Biol Phys 79(3):794\u2013799","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1249_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ygyno.2011.07.009","volume":"123","author":"S Mabuchi","year":"2011","unstructured":"Mabuchi S, Okazawa M, Isohashi F et al (2011) Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer. Gynecol Oncol 123(2):241\u2013247","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1249_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1586\/era.09.192","volume":"10","author":"M Undurraga","year":"2010","unstructured":"Undurraga M, Loubeyre P, Dubuisson JB et al (2010) Early-stage cervical cancer: is surgery better than radiotherapy? Expert Rev Anticancer Ther 10(3):451\u2013460","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"1249_CR25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMoa1309748","volume":"370","author":"KS Tewari","year":"2014","unstructured":"Tewari KS, Sill MW, Long HJ 3rd et al (2014) Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 370(8):734\u2013743","journal-title":"N Engl J Med"},{"issue":"28","key":"1249_CR26","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1200\/JCO.2009.21.8909","volume":"27","author":"BJ Monk","year":"2009","unstructured":"Monk BJ, Sill MW, McMeekin DS et al (2009) Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 27(28):4649\u20134655","journal-title":"J Clin Oncol"},{"issue":"19","key":"1249_CR27","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","volume":"33","author":"R Kitagawa","year":"2015","unstructured":"Kitagawa R, Katsumata N, Shibata T et al (2015) Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol 33(19):2129\u20132135","journal-title":"J Clin Oncol"},{"issue":"4","key":"1249_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10147-016-0955-3","volume":"21","author":"M Takekuma","year":"2016","unstructured":"Takekuma M, Kasamatsu Y, Kado N et al (2016) Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol 21(4):741\u2013747","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"1249_CR29","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1525-1438.2007.01136.x","volume":"18","author":"KB Lee","year":"2008","unstructured":"Lee KB, Lee JM, Ki KD et al (2008) Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancer. Int J Gynecol Cancer 18(5):1027\u20131031","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"1249_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/jso.22136","volume":"105","author":"M Hosaka","year":"2012","unstructured":"Hosaka M, Watari H, Kato T et al (2012) Clinical efficacy of paclitaxel\/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy. J Surg Oncol 105(6):612\u2013616","journal-title":"J Surg Oncol"},{"issue":"9","key":"1249_CR31","doi-asserted-by":"publisher","first-page":"e73837","DOI":"10.1371\/journal.pone.0073837","volume":"8","author":"S Li","year":"2013","unstructured":"Li S, Hu T, Chen Y et al (2013) Adjuvant chemotherapy, a valuable alternative option in selected patients with cervical cancer. PLoS One 8(9):e73837","journal-title":"PLoS One"},{"issue":"2","key":"1249_CR32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ygyno.2006.04.019","volume":"103","author":"N Takeshima","year":"2006","unstructured":"Takeshima N, Umayahara K, Fujiwara K et al (2006) Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer. Gynecol Oncol 103(2):618\u2013622","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1249_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1447-0756.2008.00739.x","volume":"34","author":"M Hosaka","year":"2008","unstructured":"Hosaka M, Watari H, Takeda M et al (2008) Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy. J Obstet Gynaecol Res 34(4):552\u2013556","journal-title":"J Obstet Gynaecol Res"},{"issue":"7","key":"1249_CR34","doi-asserted-by":"publisher","first-page":"e0132298","DOI":"10.1371\/journal.pone.0132298","volume":"10","author":"PS Jung","year":"2015","unstructured":"Jung PS, Kim DY, Lee SW et al (2015) Clinical role of adjuvant chemotherapy after radical hysterectomy for FIGO stage IB-IIA cervical cancer: comparison with adjuvant RT\/CCRT using inverse-probability-of-treatment weighting. PLoS One 10(7):e0132298","journal-title":"PLoS One"},{"issue":"3","key":"1249_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(08)70074-3","volume":"9","author":"D Querleu","year":"2008","unstructured":"Querleu D, Morrow CP (2008) Classification of radical hysterectomy. Lancet Oncol 9(3):297\u2013303","journal-title":"Lancet Oncol"},{"issue":"5","key":"1249_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ijc.30793","volume":"141","author":"K Matsuo","year":"2017","unstructured":"Matsuo K, Shimada M, Aoki Y et al (2017) Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: systemic chemotherapy versus pelvic irradiation. Int J Cancer 141(5):1042\u20131051","journal-title":"Int J Cancer"},{"key":"1249_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12885-016-2447-2","volume":"16","author":"L Li","year":"2016","unstructured":"Li L, Song X, Liu R et al (2016) Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study. BMC Cancer 16:403","journal-title":"BMC Cancer"},{"issue":"8","key":"1249_CR38","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/annonc\/mdg333","volume":"14","author":"A Duenas-Gonzalez","year":"2003","unstructured":"Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A et al (2003) A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 14(8):1278\u20131284","journal-title":"Ann Oncol"},{"issue":"1","key":"1249_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ygyno.2003.09.015","volume":"92","author":"DC Park","year":"2004","unstructured":"Park DC, Kim JH, Lew YO et al (2004) Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 92(1):59\u201363","journal-title":"Gynecol Oncol"},{"issue":"8","key":"1249_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12032-017-0992-4","volume":"34","author":"M Tanioka","year":"2017","unstructured":"Tanioka M, Yamaguchi S, Shimada M et al (2017) Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study. Med Oncol 34(8):134","journal-title":"Med Oncol"},{"issue":"3","key":"1249_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/IGC.0b013e31828703fd","volume":"23","author":"M Okazawa","year":"2013","unstructured":"Okazawa M, Mabuchi S, Isohashi F et al (2013) Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. Int J Gynecol Cancer 23(3):567\u2013575","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1249_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ygyno.2010.09.016","volume":"120","author":"S Mabuchi","year":"2011","unstructured":"Mabuchi S, Okazawa M, Isohashi F et al (2011) Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases. Gynecol Oncol 120(1):94\u2013100","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1249_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10147-007-0661-2","volume":"12","author":"N Sakuragi","year":"2007","unstructured":"Sakuragi N (2007) Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol 12(3):165\u2013175","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"1249_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejso.2006.09.037","volume":"33","author":"QD Pieterse","year":"2007","unstructured":"Pieterse QD, Kenter GG, Gaarenstroom KN et al (2007) The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol 33(2):216\u2013221","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"1249_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ygyno.2016.02.011","volume":"141","author":"S Mabuchi","year":"2016","unstructured":"Mabuchi S, Isohashi F, Yokoi T et al (2016) A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes. Gynecol Oncol 141(2):240\u2013246","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1249_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","volume":"65","author":"M Rotman","year":"2006","unstructured":"Rotman M, Sedlis A, Piedmonte MR et al (2006) A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65(1):169\u2013176","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1249_CR47","unstructured":"NCT01101451. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01101451 . Accessed 11 June 2017"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1249-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T04:13:48Z","timestamp":1603858428000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1249-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1249-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}